Mary Crowley Medical Research Center
3 clinical trials · Sponsor
◉ Watch Mary Crowley Medical Research Center
| Record | Firm | Date |
|---|---|---|
| Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers (NCT02725489) | Mary Crowley Medical Research Center | 2016-06-03 |
| Blood for Immune Response to Provenge® in HRPC (NCT01274572) | Mary Crowley Medical Research Center | 2011-01-01 |
| Phase I Trial of TGFB2-Antisense-GMCSF Gene Modified Autologous Tumor Cell (TAG) Vaccine for Advanced Cancer (NCT00684294) | Mary Crowley Medical Research Center | 2008-05-27 |
Track Mary Crowley Medical Research Center automatically
Every clearance here is in the API, with alerts when new ones post.